Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Melanoma

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 59 articles:
HTML format



Single Articles


    June 2021
  1. CURTI BD, Faries MB
    Recent Advances in the Treatment of Melanoma.
    N Engl J Med. 2021;384:2229-2240.
    PubMed    


    April 2021
  2. ADAMSON AS, Mazer BL, Welch HG
    The Rapid Rise in Cutaneous Melanoma Diagnoses. Reply.
    N Engl J Med. 2021;384:e54.
    PubMed    


  3. GOLDSMITH SM
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:e54.
    PubMed    


  4. GROSSMAN D, Sweeney C, Doherty JA
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:e54.
    PubMed    


    January 2021
  5. WELCH HG, Mazer BL, Adamson AS
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:72-79.
    PubMed    


    December 2020
  6. LEMAITRE S, Arora A
    Iridociliary Melanoma.
    N Engl J Med. 2020;383:e133.
    PubMed    


    September 2020
  7. DUMMER R, Hauschild A, Santinami M, Atkinson V, et al
    Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
    N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2005493.
    PubMed     Abstract available


    July 2020
  8. PARODI M, Errichetti E
    Eruptive Mucosal and Ungual Melanoma Metastases.
    N Engl J Med. 2020;383:169.
    PubMed    


    June 2020
  9. FRYE BC, Meiss F, von Bubnoff D, Zissel G, et al
    Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis.
    N Engl J Med. 2020;382:2573-2574.
    PubMed    


    May 2020
  10. ARMSTRONG KA, Cohen JV, Shepard JO, Folch EE, et al
    Case 16-2020: A 47-Year-Old Woman with Recurrent Melanoma and Pulmonary Nodules.
    N Engl J Med. 2020;382:2034-2043.
    PubMed    


    March 2020
  11. REYNOLDS KL, Sullivan RJ, Fintelmann FJ, Mansour MK, et al
    Case 9-2020: A 64-Year-Old Man with Shortness of Breath, Cough, and Hypoxemia.
    N Engl J Med. 2020;382:1150-1159.
    PubMed    


    January 2020
  12. LIM AHW, Argyrides J
    Gastrointestinal Bleeding from Metastatic Melanoma.
    N Engl J Med. 2020;382:e7.
    PubMed    


  13. APOSTOLOVA P, Unger S, von Bubnoff D, Meiss F, et al
    Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy.
    N Engl J Med. 2020;382:294-296.
    PubMed    


    November 2019
  14. LUO Z, Zhao S
    A Bleeding Toe.
    N Engl J Med. 2019;381:1853.
    PubMed    


    September 2019
  15. LARKIN J, Chiarion-Sileni V, Gonzalez R, Grob JJ, et al
    Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1910836.
    PubMed     Abstract available


    June 2019
  16. ESFAHANI K, Buhlaiga N, Thebault P, Lapointe R, et al
    Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy.
    N Engl J Med. 2019;380:2375-2376.
    PubMed    


  17. ROBERT C, Grob JJ, Stroyakovskiy D, Karaszewska B, et al
    Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
    N Engl J Med. 2019 Jun 4. doi: 10.1056/NEJMoa1904059.
    PubMed     Abstract available


    May 2019
  18. EVERETT L, Copperman T
    Metastatic Uveal Melanoma.
    N Engl J Med. 2019;380:1853.
    PubMed    


    April 2019
  19. LONG GV, Gasal E, Hauschild A
    Estimation of Distant Metastasis-free Survival in Trials of Adjuvant Therapy for Melanoma. Reply.
    N Engl J Med. 2019;380:1376-1377.
    PubMed    


  20. EGGERMONT A, Suciu S, Kicinski M
    Estimation of Distant Metastasis-free Survival in Trials of Adjuvant Therapy for Melanoma.
    N Engl J Med. 2019;380:1374-1376.
    PubMed    


  21. RAJKOMAR A, Dean J, Kohane I
    Machine Learning in Medicine.
    N Engl J Med. 2019;380:1347-1358.
    PubMed    


    March 2019
  22. PIANA S, Longo C
    Diffuse Melanosis and Melanuria.
    N Engl J Med. 2019;380:1166.
    PubMed    


    February 2019
  23. SAFA H, Glitza Oliva IC
    Cardiac Metastases in Melanoma.
    N Engl J Med. 2019;380:858.
    PubMed    


    November 2018
  24. MANSOURI A, Moraes FY, Zadeh G
    Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
    N Engl J Med. 2018;379:2177-8.
    PubMed    



  25. Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
    N Engl J Med. 2018;379:2177-2178.
    PubMed    


  26. MANLEY C, Olszanski A
    Melanoma in the Bronchus.
    N Engl J Med. 2018;379:e36.
    PubMed    


    August 2018
  27. TURAJLIC S, Larkin J
    Immunotherapy for Melanoma Metastatic to the Brain.
    N Engl J Med. 2018;379:789-790.
    PubMed    


  28. TAWBI HA, Forsyth PA, Algazi A, Hamid O, et al
    Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
    N Engl J Med. 2018;379:722-730.
    PubMed     Abstract available


  29. BARKER CA
    Adjuvant Pembrolizumab in Resected Stage III Melanoma.
    N Engl J Med. 2018;379:593.
    PubMed    



  30. Adjuvant Pembrolizumab in Resected Stage III Melanoma.
    N Engl J Med. 2018;379:593-595.
    PubMed    


    April 2018

  31. More on Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:1656-1657.
    PubMed    


  32. EGGERMONT AMM, Blank CU, Mandala M, Long GV, et al
    Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
    N Engl J Med. 2018 Apr 15. doi: 10.1056/NEJMoa1802357.
    PubMed     Abstract available


    February 2018
  33. WEBER J, Qureshi A, Ascierto PA
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:680.
    PubMed    


  34. MARIA ARJ, Viegas Dias C, Heleno B
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:679.
    PubMed    


  35. THOMSON N, Doerr R, Martin MG
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:678-9.
    PubMed    


  36. SLADDEN M, Zagarella S, Bigby M
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:678.
    PubMed    



  37. Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:678-680.
    PubMed    


    January 2018
  38. CAULLEY L, Balch CM, Ross MI, Robert C, et al
    Management of Sentinel-Node Metastasis in Melanoma.
    N Engl J Med. 2018;378:85-88.
    PubMed    


    December 2017
  39. ALEGRE-DEL-REY EJ, de la Nogal Fernandez B, Briceno-Casado P
    Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017;377:2503.
    PubMed    


  40. RYU H, Lee HJ
    Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017;377:2503.
    PubMed    


  41. KOURKOUMPETIS T, Jarbrink-Sehgal ME
    Melanoma Metastatic to the Duodenum.
    N Engl J Med. 2017;377:e34.
    PubMed    


  42. WOLCHOK JD, Rollin L, Larkin J
    Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017;377:2503-2504.
    PubMed    


    November 2017
  43. SCHUCHTER LM
    Adjuvant Melanoma Therapy - Head-Spinning Progress.
    N Engl J Med. 2017;377:1888-1890.
    PubMed    


    September 2017
  44. WOLCHOK JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, et al
    Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1709684.
    PubMed     Abstract available


  45. WEBER J, Mandala M, Del Vecchio M, Gogas HJ, et al
    Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1709030.
    PubMed     Abstract available


  46. LONG GV, Hauschild A, Santinami M, Atkinson V, et al
    Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1708539.
    PubMed     Abstract available


    August 2017
  47. BILIMORIA KY, Russell MC, Hyngstrom J
    Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:891.
    PubMed    


  48. FARIES MB, Cochran AJ, Thompson JF
    Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:892.
    PubMed    



  49. Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:891-2.
    PubMed    


    July 2017
  50. COSTELLO CM, Pittelkow MR, Mangold AR
    Acral Melanoma and Mechanical Stress on the Plantar Surface of the Foot.
    N Engl J Med. 2017;377:395-396.
    PubMed    


    June 2017
  51. COIT D
    The Enigma of Regional Lymph Nodes in Melanoma.
    N Engl J Med. 2017;376:2280-2281.
    PubMed    


  52. FARIES MB, Thompson JF, Cochran AJ, Andtbacka RH, et al
    Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
    N Engl J Med. 2017;376:2211-2222.
    PubMed     Abstract available


    May 2017
  53. GONG HZ, Li J
    Melanoma of the Foot.
    N Engl J Med. 2017;376:1867.
    PubMed    


    February 2017
  54. KRISTENSEN VN
    The Antigenicity of the Tumor Cell - Context Matters.
    N Engl J Med. 2017;376:491-493.
    PubMed    


    January 2017
  55. COPUR MS, Ramaekers R, Crockett D
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:398-9.
    PubMed    


  56. IANIRO G, Gasbarrini A, Cammarota G
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:398.
    PubMed    


  57. EGGERMONT AMM, Suciu S, Testori A, et al., et al
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:399.
    PubMed    


    November 2016
  58. JOHNSON DB, Balko JM, Compton ML, Chalkias S, et al
    Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
    N Engl J Med. 2016;375:1749-1755.
    PubMed     Abstract available


    October 2016
  59. EGGERMONT AM, Chiarion-Sileni V, Grob JJ, Dummer R, et al
    Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
    N Engl J Med. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: